Successful multi-target therapy using corticosteroid, tacrolimus, cyclophosphamide, and rituximab for rapidly progressive interstitial lung disease in a patient with clinically amyopathic dermatomyositis

Saved in:
Bibliographic Details
Published inModern rheumatology Vol. 26; no. 3; pp. 465 - 466
Main Authors Watanabe, Ryu, Ishii, Tomonori, Araki, Kyoko, Ishizuka, Mariko, Kamogawa, Yukiko, Fujita, Yoko, Shirota, Yuko, Fujii, Hiroshi, Harigae, Hideo
Format Journal Article
LanguageEnglish
Published United States Taylor & Francis 03.05.2016
Subjects
Adrenal Cortex Hormones - therapeutic use
Clinically amyopathic dermatomyositis
Cyclophosphamide - therapeutic use
Dermatomyositis - complications
Drug Therapy, Combination
Female
Humans
Immunosuppressive Agents - therapeutic use
Interstitial lung disease
Lung Diseases, Interstitial - complications
Lung Diseases, Interstitial - drug therapy
Middle Aged
Multi-target therapy
Rituximab
Rituximab - therapeutic use
Tacrolimus - therapeutic use
Treatment Outcome
Rituximab
Clinically amyopathic dermatomyositis
Interstitial lung disease
Multi-target therapy
Online AccessGet full text

Cover

More Information
Bibliography:ObjectType-Case Study-2
SourceType-Scholarly Journals-1
ObjectType-Feature-4
content type line 23
ObjectType-Report-1
ObjectType-Article-3
ISSN:1439-7595
1439-7609
1439-7609
DOI:10.3109/14397595.2015.1012797